Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
Julphar
Teva
Fish and Richardson
Citi
Accenture
US Army
Covington

Generated: November 20, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Indibulin

« Back to Dashboard

US Patents for Indibulin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Indibulin ➤ Sign Up N-substituted indole-3 glyoxylamides having anti-asthmatic antiallergic and immunosuppressant/immuno-modulating action ASTA Medica Aktiengesellschgt (DE) ➤ Sign Up
Indibulin ➤ Sign Up Indolyl-3-glyoxylic acid derivatives having antitumor action Asta Medica Aktiengesellschaft (Dresden, DE) ➤ Sign Up
Indibulin ➤ Sign Up N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action ASTA Medica AG (Frankfurt am Main, DE) ➤ Sign Up
Indibulin ➤ Sign Up Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties Baxter Healthcare SA (Wallisellen, CH) ➤ Sign Up
Indibulin ➤ Sign Up 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity Novuspharma S.p.A. (Milan, IT) ➤ Sign Up
Indibulin ➤ Sign Up Indol-3-YL-2-oxoacetamide compounds and methods of use thereof National Health Research Institutes (Miaoli Country, TW) ➤ Sign Up
Indibulin ➤ Sign Up N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action ASTA MEDICA, Aktiengesellschaft (Dresden, DE) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Indibulin

Drugname Country Document Number Estimated Expiration Related US Patent
Indibulin Argentina 008630 2016-09-06 ➤ Sign Up
Indibulin Austria 342889 2016-09-06 ➤ Sign Up
Indibulin Australia 4015897 2016-09-06 ➤ Sign Up
Indibulin Australia 726521 2016-09-06 ➤ Sign Up
Indibulin Brazil 9712808 2016-09-06 ➤ Sign Up
Indibulin Canada 2215013 2016-09-06 ➤ Sign Up
Indibulin China 100376554 2016-09-06 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKinsey
Mallinckrodt
Fish and Richardson
Cerilliant
Teva
Dow
Moodys
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.